CARsgen Therapeutics Holdings Limited (HKG:2171)

HKG:2171 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,261	1,479	1,850	2,268	691.28	1,043
Short-Term Investments	-	0.84	1.13	6.31	2,321	1.81
Cash & Short-Term Investments	1,261	1,480	1,851	2,274	3,012	1,045
Cash Growth	-23.71%	-20.04%	-18.62%	-24.50%	188.31%	961.37%
Accounts Receivable	18.55	18.29	-	-	-	-
Other Receivables	41.28	14.52	11.82	16.58	49.05	5.91
Receivables	59.83	32.8	11.82	16.58	49.05	5.91
Inventory	11.12	6.93	0.68	-	-	-
Other Current Assets	48.15	10.65	9.71	9.72	9.57	5.1
Total Current Assets	1,380	1,530	1,873	2,301	3,071	1,056
Property, Plant & Equipment	110.88	123.95	361.39	441.38	386.19	156.77
Other Intangible Assets	3.58	2.94	8.66	14.48	20.13	23.52
Other Long-Term Assets	19.05	15.87	14.08	6.32	28.46	17.77
Total Assets	1,513	1,673	2,257	2,763	3,506	1,254
Accrued Expenses	149.1	171.37	151.04	137.2	94.71	59.11
Current Portion of Long-Term Debt	-	20.29	2.52	4.85	219.33	68.37
Current Portion of Leases	13.61	13.44	12.23	17.13	14.03	5.89
Current Income Taxes Payable	2.86	-	-	1.34	7.65	-
Current Unearned Revenue	43.07	38.66	23.46	6.57	10.14	3.59
Other Current Liabilities	5.15	10.25	6.97	3.92	43.32	8.27
Total Current Liabilities	213.8	254.01	196.22	171	389.17	145.23
Long-Term Debt	71.6	68.85	-	2.52	7.38	11.98
Long-Term Leases	55.64	63.84	70.47	94.94	97.31	14.02
Long-Term Unearned Revenue	210.22	229.63	188.83	21.18	15.12	13.17
Other Long-Term Liabilities	-	-	-	-	-	2,746
Total Liabilities	551.26	616.33	455.51	289.65	508.98	2,930
Common Stock	0	0	0	0	0	-
Additional Paid-In Capital	-	9,388	9,437	9,430	9,420	-
Retained Earnings	-	-8,988	-8,190	-7,442	-6,550	-1,823
Comprehensive Income & Other	962.13	656.5	554.6	484.89	126.63	146.68
Shareholders' Equity	962.13	1,057	1,802	2,473	2,997	-1,676
Total Liabilities & Equity	1,513	1,673	2,257	2,763	3,506	1,254
Total Debt	140.86	166.42	85.22	119.45	338.05	100.26
Net Cash (Debt)	1,120	1,313	1,766	2,155	2,674	944.52
Net Cash Growth	-22.20%	-25.61%	-18.06%	-19.42%	183.13%	1905.02%
Net Cash Per Share	2.04	2.38	3.17	3.91	6.91	4.77
Filing Date Shares Outstanding	553.73	549.41	575.64	572.63	567.54	198.14
Total Common Shares Outstanding	553.73	549.41	575.64	572.63	567.54	198.14
Working Capital	1,166	1,276	1,677	2,130	2,682	910.56
Book Value Per Share	1.74	1.92	3.13	4.32	5.28	-8.46
Tangible Book Value	958.56	1,054	1,793	2,459	2,977	-1,700
Tangible Book Value Per Share	1.73	1.92	3.11	4.29	5.24	-8.58
Buildings	-	81.9	81.32	80.92	36.82	36.82
Machinery	-	216.87	217.89	201.82	176.69	137.49
Construction In Progress	-	12.68	2.13	12.15	152.14	-
Leasehold Improvements	-	199.2	200.93	197.47	11.79	3.02

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.